ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Moderna Inc

Moderna Inc (MRNA)

40.76
-1.08
(-2.58%)
Closed December 17 3:00PM
40.76
0.00
(0.00%)
After Hours: 6:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
40.76
Bid
40.74
Ask
40.79
Volume
6,266,846
40.63 Day's Range 43.166
35.80 52 Week Range 170.47
Market Cap
Previous Close
41.84
Open
41.85
Last Trade
20
@
40.78
Last Trade Time
Financial Volume
US$ 261,712,695
VWAP
41.7615
Average Volume (3m)
7,168,480
Shares Outstanding
384,817,811
Dividend Yield
-
PE Ratio
-3.33
Earnings Per Share (EPS)
-12.25
Revenue
6.85B
Net Profit
-4.71B

About Moderna Inc

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Moderna Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MRNA. The last closing price for Moderna was US$41.84. Over the last year, Moderna shares have traded in a share price range of US$ 35.80 to US$ 170.47.

Moderna currently has 384,817,811 shares outstanding. The market capitalization of Moderna is US$16.10 billion. Moderna has a price to earnings ratio (PE ratio) of -3.33.

Moderna (MRNA) Options Flow Summary

Overall Flow

Bearish

Net Premium

-155M

Calls / Puts

18.67%

Buys / Sells

135.14%

OTM / ITM

23.61%

Sweeps Ratio

1.12%

MRNA Latest News

Annual Changes to the Nasdaq-100 Index®

NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX®), which will become effective...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4.7-10.338759348945.4645.4940.6705684338942.05484579CS
41.814.6469833119438.9547.412635.96804798741.84289934CS
12-24.07-37.127872898364.8367.959835.8716848047.53527218CS
26-97.15-70.4444927851137.91139.9235.8577201166.06756701CS
52-45.11-52.532898567685.87170.4735.8502749785.64050366CS
156-234.74-85.2050816697275.5321.30535.85104984128.86415027CS
26022.22119.84897518918.54497.1717.689276371145.5515208CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUKKNukkleus Inc
US$ 11.655
(738.49%)
174.4M
PRTGPortage Biotech Inc
US$ 8.8678
(172.86%)
36.61M
OPTXSyntec Optics Holdings Inc
US$ 3.55
(99.44%)
93.16M
PTPIPetros Pharmaceuticals Inc
US$ 0.4976
(86.37%)
63.49M
LUXHLuxUrban Hotels Inc
US$ 0.849899
(59.67%)
29.52M
VCNXVaccinex Inc
US$ 1.41
(-61.37%)
758.95k
TNYATenaya Therapeutics Inc
US$ 1.395
(-51.56%)
42.45M
ORKTOrangeKloud Technology Inc
US$ 2.14
(-41.85%)
2.29M
RVPHReviva Pharmaceuticals Holdings Inc
US$ 1.395
(-39.35%)
18.16M
DBGIDigital Brands Group Inc
US$ 2.46
(-37.88%)
805.23k
RIMEAlgorhythm Holdings Inc
US$ 0.0877
(8.27%)
1.13B
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.335
(-36.79%)
1.02B
GOEVCanoo Inc
US$ 0.118
(7.08%)
388.43M
NVDANVIDIA Corporation
US$ 130.39
(-1.22%)
259.4M
XTIAXTI Aerospace Inc
US$ 0.0442
(8.33%)
222.55M

MRNA Discussion

View Posts
bwrbad bwrbad 1 day ago
next big thing is what coming from RXRX, MRNA covid flu vacc had its day - it is another flu and everyone knows how to handle better than flu even without booster.
👍️0
axelvento axelvento 3 days ago
Mitch McConnell warns RFK Jr. against effort to undermine polio vaccines

"Anyone seeking the Senate's consent to serve in the incoming Administration would do well to steer clear of even the appearance of association with such efforts," McConnell said in a statement.

"The polio vaccine has saved millions of lives and held out the promise of eradicating a terrible disease

https://www.cbsnews.com/news/rfk-jr-mitch-mcconnell-polio-vaccine/
👍️ 3 🔝 1
axelvento axelvento 6 days ago
Moderna’s mRNA vaccines to be exempt from advisory committee scrutiny under $2bn Morrison-era deal

The contract signed with the American pharmaceutical company in 2021 commits successive Australian governments to buying locally produced Moderna vaccines for at least a decade.

https://www.theguardian.com/australia-news/2024/dec/10/moderna-mrna-vaccine-exempt-advisory-committee-pbac-scott-morrison
👍️ 2 💪 1
Vexari Vexari 6 days ago
What entities willfully and criminally engaged

~~~ In racketeering, illegal advertising, fraud ~~~
(59:55)

And mass premeditated murder

Of millions of innocent people worldwide

Criminal indictments

NoVacc4Me
👎️ 1 💊 1 🕳️ 1 🗑️ 1 🤪 1
axelvento axelvento 7 days ago
Down on FDA halted trial for rsv for babies as a precaution. Moderna discontinued the trial back in September anyways. No set back. Just need positive CMV data.
👍️ 1 ✌️ 1
axelvento axelvento 7 days ago
After safety signal in
moderna
's trial forced vaccinemaker to end study

US_FDA
disclosed today that enrollment of young children is now

"on hold for all clinical studies of RSV vaccine candidates under U.S. IND"

https://www.fda.gov/media/184301/download

RELAX$
👋 1 👍️ 2
DewDiligence DewDiligence 1 week ago
MRNA—(-9%)—downgraded by BofA:

https://www.barrons.com/articles/moderna-amgen-regeneron-stock-price-bofa-rating-1b1f584f Moderna was down in Tuesday trading after a bearish call from BofA Securities sent shares lower. Analysts led by Tim Anderson relaunched coverage of 11 large-cap U.S. pharma and biotech names in a Tuesday report. The team rates Eli Lilly, Gilead, and Merck at Buy; AbbVie, Biogen, Bristol-Meyers Squibb, Johnson & Johnson, and Pfizer at Neutral; and Amgen, Moderna, and Regeneron at Underperform.

[MRNA] has tumbled 55% this year. Uncertainty around its Covid-19 products and Trump’s possible appointees have weighed on shares.

“…by the company’s own guidance, it won’t be cash EPS positive until 2028 (we model 2029),” BofA wrote, adding that its RSV vaccine isn’t likely to have a sizable impact and the true value of the company’s pipeline remains unclear.
👍️0
axelvento axelvento 1 week ago
Trump also dismissed the notion that he opposes all vaccines. He expressed support for Kennedy’s stated position for placing them under increased scrutiny, particularly when it comes to protecting children, and pointed out how autism diagnoses have spiked in recent decades.

“I’m not against vaccines,” Trump said. “The Polio vaccine is the greatest thing. If somebody told me to get rid of the Polio vaccine, they’re going to have to work real hard to convince me. I think … certain vaccines are incredible, but maybe some aren’t. And if they aren’t, we have to find out.”

https://www.dailywire.com/news/a-little-unusual-trump-opens-up-about-meeting-with-rfk-jr-dr-oz-and-drug-company-execs
👋 1 👍️ 3
axelvento axelvento 2 weeks ago
Webcast: https://investors.modernatx.com/overview/default.aspx
👌 2 👍️ 2
axelvento axelvento 2 weeks ago
04 Dec, 2024Moderna opens world-leading vaccine facility in Victoria

The Southern Hemisphere’s only commercial-scale end-to-end mRNA manufacturing facility has opened in Victoria, backed by both the Australian and Victorian Governments. This landmark development will enable the production of world-class mRNA vaccines and medicines in Australia, strengthening Victoria’s leadership in mRNA technology, both globally and nationally.

https://www.invest.vic.gov.au/news-and-events/news/2024/december/moderna-opens-world-leading-vaccine-facility-in-victoria
👍️ 2 😄 1
axelvento axelvento 2 weeks ago
BECOMING MORE AIRBORNE—New study in Nature says that the newer H5N1 bird flu variants are becoming more airborne than older bird flu variants. This is extremely worrisome. Virus will always try to adapt to be more adept at transmission and infection ability—Evolution arms race.

https://www.nature.com/articles/s41564-024-01885-6
👍️ 2 🙃 1
axelvento axelvento 2 weeks ago
Dr. Dave Weldon, Trump’s C.D.C. Pick, Was Not on Anyone’s Radar

Both his adult children are fully immunized, he said, and he prescribes thousands of doses of flu and other vaccines to his adult patients. “I’ve been described as anti-vaccine,” Dr. Weldon said, but “I give shots, I believe in vaccination.”

https://www.nytimes.com/2024/11/29/health/dave-weldon-cdc.html
👋 1 👍️ 1
axelvento axelvento 3 weeks ago
NEXT> Why a teenager’s bird-flu infection is ringing alarm bells for scientists

https://www.nature.com/articles/d41586-024-03805-4
👀 1 👍️ 1
axelvento axelvento 3 weeks ago
Johns Hopkins surgeon Makary is Trump’s pick to lead FDA "pro-vaccine"

https://www.healthcaredive.com/news/trump-fda-martin-makary-surgeon-nominate/733829/
👌 2 👍️ 1
reyprimero reyprimero 4 weeks ago
Mrna undervalued a lot, time to load the truck, IMO
👍️ 2 💯 3
Vexari Vexari 4 weeks ago
Manipulation is key

To the equation
👎️ 1 🗑️ 1 🚽 1 🤪 1 ⤵️ 1
axelvento axelvento 4 weeks ago
Our question is, what data is Mr. Kennedy talking about? Comprehensive national vaccine safety data are readily available to anyone. This includes the safety data used to license vaccines and data gathered after they have gone into use

https://www.nytimes.com/2024/11/20/opinion/rfk-jr-vaccines-public-health.html

$MRNA
👍️ 2 😄 1
axelvento axelvento 4 weeks ago
HSBC upgrades to Buy on underestimated pipeline potential
👍️ 2 🤙 1
axelvento axelvento 4 weeks ago
Trump gives RFK Jr McDonald’s ‘poison’ to eat on private plane

https://www.yahoo.com/news/trump-gives-rfk-jr-mcdonald-133657991.html
👍️ 1 😴 1 🤣 1
axelvento axelvento 1 month ago
Bears need to take into consideration the CMV data coming our this quarter. It's a 3-5 TAM drug with no competitors
I'd be careful shorting this right now!
👍️ 1
Stock Guy777 Stock Guy777 1 month ago
Amen to that!
👍️0
axelvento axelvento 1 month ago
Kennedy’s spokesperson did not respond to my request for comment last night as to whether, as HHS secretary, RFK Jr. would move to outlaw any existing vaccines, and referred me to his victory-lap post on X, which did not mention the topic

https://www.theatlantic.com/politics/archive/2024/11/trump-health-human-services-nomination/680674/

clown-
👍️0
axelvento axelvento 1 month ago
I agree$$$$$$$$
👍️0
DewDiligence DewDiligence 1 month ago
He won't be confirmed by the Senate, in my opinion.
👍️ 2 🙏 1 🤞 1
Stock Guy777 Stock Guy777 1 month ago
By the looks of the chart it has been finished! This thing was well into the 300s when I traded it from $80’s to 300+ and now look at it!! Look Out below! Just decided to come back and take a look. It’s obviously done horrible as did the” Shot”
👍️ 1
Bountiful_Harvest Bountiful_Harvest 1 month ago
Vaccine Stocks Slide Further After Trump Taps RFK Jr. To Lead HHS; CNN Outraged

https://www.zerohedge.com/markets/vaccine-stocks-slide-further-after-trump-taps-rfk-jr-lead-hhs

Moderna is finished...
👍️ 1
Stock Guy777 Stock Guy777 1 month ago
Yeah, good for you. I played this back in the day. And got out. I was never a fan, just knew before the actual vaccine was created, that it would run up.
👍️0
Stock Guy777 Stock Guy777 1 month ago
Yeah, for the better! Finally stopping these Frankenstein doctors and their controversial “shots” that play havoc on your whole body that I believe potentially killed my father early
👍️ 1
spartex spartex 1 month ago
Well right now it is having a huge impact on MRNA longs that are deeply under water if they haven't hedged with puts.

A four year low going all the way back to April 2020 period. Brutal. Glad I alerted the troops on this news yesterday to save themselves 7% or more downward draft today!
👍️0
axelvento axelvento 1 month ago
Trump’s latest controversial Cabinet pick could have a huge impact on Americans’ health and lives
https://edition.cnn.com/2024/11/15/politics/trump-rfk-cabinet-pick-american-health-analysis/index.html

the game$$$$$$$
👍️ 1 🤟 1
axelvento axelvento 1 month ago
RFK Jr. has built a reputation as a vaccine skeptic but has stopped short of adopting the “anti-vaxx” label attributed to him by critics. The former environmental lawyer has said his children are vaccinated and that he does not oppose safe vaccines.

relax$
👍️ 1 😃 1
axelvento axelvento 1 month ago
Kennedy has been one of the country’s most prominent anti-vaccine conspiracy theorists for years and has frequently spread falsehoods about the safety and efficacy of vaccines. Last week, Kennedy said he would “immediately” begin studying vaccine safety and efficacy but promised to not “take vaccines away from anybody.”
👍️0
Bountiful_Harvest Bountiful_Harvest 1 month ago
Shares of $MRNA and other hot shot stocks in full collapse on news of RFK joining the Trump admin

👍️0
spartex spartex 1 month ago
Big selling all of a sudden. Sub $40 now. 52 week low.

Appears that Trump will nominate Rfk Jr. to Health and Human Services Admin.

https://www.politico.com/news/2024/11/14/robert-f-kennedy-jr-trump-hhs-secretary-pick-00188617
😜 1
axelvento axelvento 1 month ago
next-
https://www.theguardian.com/society/2024/oct/23/doctors-trial-worlds-first-vaccine-against-vomiting-bug-norovirus
👍️ 4 🔜 1
Vexari Vexari 1 month ago
The majority shareholder of Moderna is?

When you are suffering

They are profiting
👇️ 1 🗑️ 1 🚽 1 🤪 1 🧻 1
axelvento axelvento 1 month ago
https://www.biospace.com/job-trends/biospace-announces-2025-best-places-to-work-in-biopharma
👋 1 👍 1
axelvento axelvento 1 month ago
Jpmorgan Chase & Co ownership in MRNA / Moderna, Inc.
On November 8, 2024 - Jpmorgan Chase & Co filed a 13F-HR form disclosing ownership of 2,227,044 shares of Moderna, Inc. (US:MRNA) valued at $148,833,351 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 12, 2024 disclosing 1,756,708 shares of Moderna, Inc.. This represents a change in shares of 26.77% during the quarter. The current value of the position is $104,292,471 USD.

https://fintel.io/so/us/mrna/jpmorgan-chase-
👍 2
axelvento axelvento 1 month ago
https://www.acsh.org/news/2024/11/07/dont-be-afraid-mrna-vaccines-49111
👍️ 3 🤙 1
axelvento axelvento 1 month ago
Moderna Buys Norwood Campus for $400M

https://bankerandtradesman.com/moderna-buys-norwood-campus-for-400m/#:~:text=Lab%20developer%20Alexandria%20Real%20Estate,core%20properties%20in%20Greater%20Boston.
👍️ 3 😀 1
axelvento axelvento 1 month ago
Moderna (MRNA) Q3 2024 Earnings Call Transcript

https://www.fool.com/earnings/call-transcripts/2024/11/07/moderna-mrna-q3-2024-earnings-call-transcript/
👍️ 4 ✌️ 1
EarningsCentral EarningsCentral 1 month ago
👍️0
axelvento axelvento 1 month ago
MRNA is set to report third-quarter 2024 earnings on Nov. 7, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $1.25 billion and a loss of $1.91 per share, respectively
👍️0
axelvento axelvento 2 months ago
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

https://investors.modernatx.com/news/news-details/2024/Merck-and-Moderna-Initiate-Phase-3-Trial-Evaluating-Adjuvant-V940-mRNA-4157-in-Combination-with-KEYTRUDA-pembrolizumab-After-Neoadjuvant-KEYTRUDA-and-Chemotherapy-in-Patients-With-Certain-Types-of-Non-Small-Cell-Lung-Cancer-NSCLC/default.aspx


huge news$
👍️ 1 🤑 1
axelvento axelvento 2 months ago
https://www.investing.com/news/company-news/piper-sandler-maintains-overweight-rating-on-moderna-stock-93CH-3680972
👋 1 👍️ 2
axelvento axelvento 2 months ago
20B market cap, 10B in cash, high potential pipeline in 4 therapeutic areas!
👍️ 2 💪 1
axelvento axelvento 2 months ago
Moderna has a whopping 33 million short share interest, but daily volume now a paper-thin 3.7 million

"Highest shorted stock on S&P500"
👍️ 1 🤣 1 ☝️ 1
axelvento axelvento 2 months ago
MRNA December 6th Options Begin Trading

https://www.nasdaq.com/articles/mrna-december-6th-options-begin-trading
👍️0
axelvento axelvento 2 months ago
Moderna’s norovirus vaccine enters Phase III trials in the UK
The firm hopes to file marketing applications in 2026 to have the vaccine approved by health regulators.

https://www.clinicaltrialsarena.com/news/modernas-norovirus-vaccine-enters-phase-iii-trials-in-the-uk/
👍️ 2 🤙 1
Vexari Vexari 2 months ago
Depends

On the road

That they're on
👎️ 1 🗑️ 1 🚽 1 🧻 1 0️⃣ 1

Your Recent History

Delayed Upgrade Clock